Last Updated:
12:01 pm
Tuesday, June 24, 2025
Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. It is developing the compound BIT225 for the treatment of HIV-1. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
asx-bit
Market Cap
AU$2.65M
Volume
6222
Open
0.00
AU$
High
0.00
AU$
Low
0.00
AU$
Shares On Issue
1.13B
52 Week Low
0.002
AU$
52 Week High
0.042
AU$
Website
www.biotron.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved